OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,836,523 | -45.8% | 584,880 | -10.9% | 0.00% | -33.3% |
| Q2 2023 | $3,385,502 | -41.6% | 656,105 | -40.3% | 0.00% | -50.0% |
| Q1 2023 | $5,795,788 | +113.0% | 1,099,770 | +13.6% | 0.01% | +100.0% |
| Q4 2022 | $2,721,019 | -17.2% | 968,334 | +22.2% | 0.00% | -25.0% |
| Q3 2022 | $3,288,000 | +9.3% | 792,289 | +5.9% | 0.00% | 0.0% |
| Q2 2022 | $3,009,000 | -0.9% | 748,465 | +22.0% | 0.00% | +33.3% |
| Q1 2022 | $3,037,000 | -9.2% | 613,538 | +27.9% | 0.00% | 0.0% |
| Q4 2021 | $3,343,000 | -41.1% | 479,668 | -15.4% | 0.00% | -40.0% |
| Q3 2021 | $5,671,000 | -41.8% | 567,102 | -17.5% | 0.01% | -37.5% |
| Q2 2021 | $9,744,000 | -8.9% | 687,180 | +5.4% | 0.01% | -20.0% |
| Q1 2021 | $10,701,000 | -50.8% | 652,128 | -37.9% | 0.01% | -47.4% |
| Q4 2020 | $21,730,000 | +946.2% | 1,049,746 | +284.5% | 0.02% | +850.0% |
| Q3 2020 | $2,077,000 | -40.8% | 272,988 | -35.2% | 0.00% | -50.0% |
| Q2 2020 | $3,511,000 | +1664.3% | 421,534 | +949.3% | 0.00% | – |
| Q1 2020 | $199,000 | -86.3% | 40,172 | -81.0% | 0.00% | -100.0% |
| Q3 2018 | $1,456,000 | +23.9% | 211,609 | +21.6% | 0.00% | 0.0% |
| Q2 2018 | $1,175,000 | +340.1% | 174,023 | +189.8% | 0.00% | – |
| Q4 2017 | $267,000 | -24.4% | 60,057 | +5.1% | 0.00% | -100.0% |
| Q3 2017 | $353,000 | -10.2% | 57,146 | +34.8% | 0.00% | 0.0% |
| Q2 2017 | $393,000 | -69.0% | 42,378 | -69.0% | 0.00% | -50.0% |
| Q1 2017 | $1,269,000 | +746.0% | 136,753 | +661.7% | 0.00% | – |
| Q4 2016 | $150,000 | +44.2% | 17,953 | +18.5% | 0.00% | – |
| Q3 2016 | $104,000 | -63.1% | 15,147 | -73.4% | 0.00% | -100.0% |
| Q2 2016 | $282,000 | -67.5% | 56,887 | -36.6% | 0.00% | -50.0% |
| Q1 2016 | $867,000 | +431.9% | 89,730 | +675.7% | 0.00% | – |
| Q3 2015 | $163,000 | -90.5% | 11,567 | -85.8% | 0.00% | -100.0% |
| Q2 2015 | $1,717,000 | +737.6% | 81,628 | +496.5% | 0.00% | – |
| Q3 2014 | $205,000 | – | 13,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |